217 related articles for article (PubMed ID: 8595925)
1. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
[TBL] [Abstract][Full Text] [Related]
2. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.
Kumar A; Malaviya AN; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
Immunol Res; 1994; 13(1):61-71. PubMed ID: 7897264
[TBL] [Abstract][Full Text] [Related]
3. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
[TBL] [Abstract][Full Text] [Related]
4. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
[TBL] [Abstract][Full Text] [Related]
5. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ
Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
8. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.
Mitchell JA; Sim RB; Sim E
Clin Exp Immunol; 1989 Dec; 78(3):354-8. PubMed ID: 2575471
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte CR1 (C3b/C4b receptor) levels and disease activity in patients with SLE.
Thomsen BS; Nielsen H; Andersen V
Scand J Rheumatol; 1987; 16(5):339-46. PubMed ID: 2961056
[TBL] [Abstract][Full Text] [Related]
10. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
11. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
Verma J; Arora V; Marwaha V; Kumar A; Das N
Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
[TBL] [Abstract][Full Text] [Related]
12. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
[TBL] [Abstract][Full Text] [Related]
15. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.
Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM
Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335
[TBL] [Abstract][Full Text] [Related]
16. Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.
Anand D; Kumar U; Kanjilal M; Kaur S; Das N
Clin Exp Immunol; 2014 Jun; 176(3):327-35. PubMed ID: 24433281
[TBL] [Abstract][Full Text] [Related]
17. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus.
Cohen JH; Caudwell V; Levi-Strauss M; Bourgeois P; Kazatchkine MD
Arthritis Rheum; 1989 Apr; 32(4):393-7. PubMed ID: 2565113
[TBL] [Abstract][Full Text] [Related]
19. Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.
Birmingham DJ; Gavit KF; McCarty SM; Yu CY; Rovin BH; Nagaraja HN; Hebert LA
Clin Exp Immunol; 2006 Feb; 143(2):274-80. PubMed ID: 16412051
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of CR1 (the C3b complement receptor, CD35) expression on erythrocytes of HIV-infected individuals.
Cohen JH; Geffriaud C; Caudwell V; Kazatchkine MD
AIDS; 1989 Jun; 3(6):397-9. PubMed ID: 2568845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]